| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 52.585 | 85.137 | 117.052 | 143.076 | 162.362 |
| Total Income - EUR | - | - | - | - | 0 | 55.687 | 85.138 | 117.060 | 143.078 | 162.924 |
| Total Expenses - EUR | - | - | - | - | 0 | 24.115 | 30.984 | 38.416 | 40.417 | 66.042 |
| Gross Profit/Loss - EUR | - | - | - | - | 0 | 31.572 | 54.154 | 78.643 | 102.661 | 96.882 |
| Net Profit/Loss - EUR | - | - | - | - | 0 | 31.077 | 53.303 | 77.473 | 101.230 | 92.108 |
| Employees | - | - | - | - | 0 | 3 | 4 | 4 | 4 | 4 |
Check the financial reports for the company - Ultrasuportmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 805 | 1.505 | 1.510 | 1.505 | 34.354 |
| Current Assets | - | - | - | - | 0 | 34.947 | 53.293 | 79.109 | 134.076 | 63.362 |
| Inventories | - | - | - | - | 0 | 0 | 404 | 0 | 0 | 80 |
| Receivables | - | - | - | - | 0 | 2.776 | 2.286 | 7.716 | 106.248 | 55.745 |
| Cash | - | - | - | - | 0 | 32.171 | 50.603 | 71.393 | 27.828 | 7.537 |
| Shareholders Funds | - | - | - | - | 0 | 31.118 | 53.343 | 77.513 | 101.271 | 92.148 |
| Social Capital | - | - | - | - | 0 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 0 | 4.635 | 1.456 | 3.105 | 34.309 | 5.567 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ultrasuportmed S.r.l.